Photodynamic Therapy in Cancer Treatment: Materials and Technologies

Dear Colleagues,

Photodynamic therapy (PDT) has been clinically approved to treat a variety of cancer and noncancer applications. It plays a direct role in the destruction of primary tumors, using a photosensitizer and light of the appropriate wavelength, which, together with oxygen, imparts cytotoxicity by producing reactive molecular species. In addition to therapeutic effects, photosensitizer-mediated fluorescence can also be used in image-guided surgery. Thanks to rapid advances in nanotechnology, sophisticated targeting approaches, and the emergence of nanocarriers for multiple therapeutic approaches, PDT in combination with chemotherapy, photothermal therapy, radiotherapy, and immunotherapy can significantly improve therapeutic efficacy and minimize off-target effects.

This Special Issue, Photodynamic Therapy in Cancer Treatment: Materials and Technologies, aims to publish the latest research and translational work in the field of PDT in original articles related to nanodelivery carriers, photochemical and photobiological aspects, targeted drug delivery, tumor image-guided surgery, immunogenic cell death, and PDT-based multimodal therapies of cancer.

Dr. Dan Yang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• photodynamic therapy
• targeted drug-delivery and drug-release systems
• photodiagnosis/tumor imaging
• PDT-induced immunogenic cell death
• nanomaterial-based combination therapies
• theranostics
• photosensitizer